decisionhealth Newsletters, Part B News - 2010 Issue 9 (September)
ASP fourth quarter prices increase
Subscribe or sign in to view the full article.
Article Overview
This article reviews CMS’s fourth-quarter 2010 Average Sales Price list for Part B drugs and vaccines. It covers overall market movement, notable changes among frequently billed drugs, and updates affecting selected vaccine and drug codes. The piece is useful for coding and billing professionals who track quarterly drug pricing files and CMS payment updates.
Why This Topic Matters
Quarterly ASP updates can affect claim payment expectations for Part B drugs and vaccines. Readers who bill Medicare drug claims may need to know which drugs changed, which codes were added or removed, and how CMS summarized the quarter’s pricing movement.
What You Will Learn
- How CMS summarized fourth-quarter 2010 ASP pricing movement
- What broad categories of drug and vaccine changes were noted
- How the article presents selected high-volume price increases and decreases
- Which CMS ASP file timing and effective-date details are mentioned
Who Should Read This
- Medical coders
- Billing staff
- Practice administrators
- Hospital outpatient billing staff
- Part B drug billing professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com